baber/WOPTO huggingface dataset:
Patent CA-2560815-A1 (CA)
Title: Actuator for adjusting a rotor blade pitch angle
Inventor: MOLLHAGEN KLAUS-PETER
IPC: B64C11/30
Filed: 2006-09-25
Abstract: An actuator for adjusting the pitch angle of a rotor blade of a wind turbine, which is rotatably mounted on a rotor hub, comprising a first drive element connectable with the rotor blade, a second drive element in meshing engagement with said first drive element, as well as a lubricating device for lubricating the two drive elements. The lubricating device includes a lubricant passage for the selective supply of lubricant to the portion of the first drive element and/or the portion of the second drive element meshing therewith, which are in engagement with each other in the working position of the rotor blade, as well as a supply control means for controlling the supply of lubricant through said lubricant passage in dependence on the engagement position of the two drive elements or the rotary position of the rotor blade.
Patent CA-2563091-A1 (CA)
Title: Zeolite compositions having enhanced compressive strength
Inventor: SANTRA ASHOK K
IPC: C09K8/46
Filed: 2005-03-31
Abstract: Zeolite compositions having enhanced compressive strength and methods therefor are provided. In particular, methods and compositions for wellbore treating fluids, especially settable spotting fluids having enhanced compressive strength are provided.
Patent CA-2563335-A1 (CA)
Inventor: GSCHNEIDNER DAVID
IPC: A61K31/138
Filed: 2005-04-18
Abstract: The present invention provides 8-(2-hydroxyphenoxy)octyldiethanolamine) and salts thereof, compositions containing the same and one or more active agents, and methods of administering active agents with the same. The delivery agents of the present invention are well suited for forming non-covalent mixtures with active agents for oral, intracolonic, pulmonary, and other routes of administration to animals.
Patent CA-2563943-A1 (CA)
Title: Nucleotide sequences and polypeptides encoded thereby useful for modifying nitrogen use efficiency characteristics in plants
Inventor: SCHNEEBERGER RICHARD
IPC: C07K14/415
Filed: 2005-04-25
Abstract: Isolated polynucleotides and polypeptides encoded thereby are described, together with the use of those products for making transgenic plants with increased nitrogen use efficiency. The present invention further relates to nucleotide sequences and the use of those nucleotide sequences in the genetic-engineering of plants to display enhanced nitrogen assimilatory and utilization capacities, grow larger, more efficiently or rapidly, and/or have enriched nitrogen contents in vegetative and/or reproductive plant parts and/or increased biomass. More particularly, this invention relates to producing transgenic plants engineered to have altered expression of key components in the nitrogen assimilation and utilization pathways. The engineered plants may be productively cultivated under conditions of low nitrogen fertilizer input or in nitrogen poor soils. Alternatively, the engineered plants may be used to achieve faster growing or maturing crops, higher crop yields and/or more nutritious products under ideal cultivation conditions.
Patent CA-2564994-A1 (CA)
Title: Substituted morpholine compounds for the treatment of central nervous system disorders
Inventor: GRAY DAVID LAWRENCE FIRMAN
IPC: A61K31/5377
Filed: 2005-04-19
Abstract: This invention relates to compounds of the formulae (I), (II), (III), wherein R'- Re, A, X, and Z are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.
Patent CA-2567209-A1 (CA)
Inventor: LAVERGNE FABIEN
IPC: B64C13/50
Filed: 2005-07-27
Abstract: The invention relates to an electric flight control system for aircraft elevators. According to the invention, the flight control system can be controlled in terms of load factor or rate of pitch. The inventive system comprises built-in protections in relation to load factor, incidence and pitch attitude.
Patent CA-2569990-A1 (CA)
Title: Optimization of contact lenses to reduce aberrations and methods for their design
Inventor: JONES LARRY G
IPC: G02C7/04
Filed: 2005-06-10
Abstract: The invention provides lenses that are designed by taking into account one or more of pupil size, field, and decentration.
Patent CA-2571442-A1 (CA)
Title: Safety brake for elevator without counterweight
Inventor: DE JONG JOHANNES
IPC: B66B11/08
Filed: 2005-06-06
Abstract: Traction sheave elevator without counterweight and method for braking an elevator, in which elevator the elevator car is suspended by means of hoisting ropes consisting of a single rope or several parallel ropes, said elevator having a traction sheave which moves the elevator car by means of the hoisting ropes. In the elevator, when the elevator car is moving upwards in an emergency stop situation the braking of the operating brake of the elevator is at least partially prevented for at least a part of the stopping distance of the elevator.
Patent CA-2571624-A1 (CA)
Inventor: KOCHBERGER ANDREAS
IPC: B23Q1/03
Filed: 2005-06-21
Abstract: The invention relates to a device for supporting workpieces, in particular, for multi-side coating of workpieces in a coating press, comprising a press table for housing the device and an adjusting carriage, arranged below the press table, whereby a number of support elements (1), forming the laying surface of the coating press, are provided. Each support element (1) comprises a support sleeve (2), a vertically-displaceable pin (3), housed therein, guide devices (6a, 6b; 7) and fixing devices (5; 8) for the pin (3) and a return element (12), for return of the pin (3) from an upper position into a lower position. The support elements (1) are arranged without a separation.
Patent CA-2577061-A1 (CA)
Title: Histamine h3 receptor agents, preparation and therapeutic uses
Inventor: FINLEY DON RICHARD
IPC: C07D417/10
Filed: 2005-08-15
Abstract: The present invention provides a novel compound of Formula (I) or a pharmaceutically acceptable salt thereof, having histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another, embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases.
Patent CA-2578587-A1 (CA)
Inventor: KASPAR HARALD
IPC: C08K5/14
Filed: 2005-08-08
Abstract: In accordance with one aspect of the invention, there is provided (i) an amorphous fluoropolymer that has one or more cure site components, the cure site components being contained in the amorphous fluoropolymer in an amount between 0.1 and 0.5 mol% based on the total amount of repeating units and/or (ii) the amorphous fluoropolymer is capable of being dehydrofluorinated, wherein the amorphous fluoropolymer is derivable from a polymerization of (a) one or more gaseous fluorinated monomers and (b) not more than 0.5% by weight based on the total weight of monomers of one or more olefins having a bromine or iodine atom bonded to a carbon of the double bond of the olefin.
Patent CA-2579460-A1 (CA)
Inventor: HSU JAMES
IPC: H04W88/06
Filed: 2007-02-22
Abstract: Systems and methods for connecting a mobile device to an alternate wireless network are disclosed. The method includes determining alternate ireless networks available to access by the mobile device, ordering the available alternate wireless networks by signal strength, connecting the mobile device to the alternate wireless network with a highest signal strength, measuring a quality of the connected alternate wireless network and, when the quality of the connected alternate wireless network is above a predetermined threshold, operating the mobile device over the connected alternate wireless network.
Patent CA-2580692-A1 (CA)
Title: Use of glutamic acid or salts thereof in preventing or improving functional digestive disorder
Inventor: UNEYAMA HISAYUKI
IPC: A23L27/23
Filed: 2005-09-16
Abstract: It is intended to provide an agent and a food for preventing/improving functional digestive disorder which contains, as the active ingredient, at least one member selected from among glutamic acid, 5~-nucleotides and salts thereof.
Patent CA-2582131-A1 (CA)
Title: Device for adjusting an optical fiber or an optical fiber bundle
Inventor: FEHRER DIRK-OLIVER
IPC: G02B6/38
Filed: 2005-09-12
Abstract: Disclosed is a device for adjusting an optical fiber or an optical fiber bundle relative to a coupling point.  Said device comprises a holding apparatus for the fiber/s and a mechanism for positioning the fiber/s in said holding apparatus. The positioning mechanism is provided with at least two positioning members which act upon the fiber/s at different angles, the position of the fiber/s relative to the holding apparatus being modifiable by actuating said at least two positioning members. The inventive device is characterized in that the positioning members which are effective at different angles are disposed next to each other in the holding apparatus in order to be actuated from one side while at least one of the positioning members acts upon the fiber/s via a lever assembly.
Patent CA-2582242-A1 (CA)
Title: Method of insertion of a lipid-linked moiety into a pre-formed lipid    assembly using microwaves
Inventor: BARENHOLZ YECHEZKEL
IPC: A61K9/107
Filed: 2005-10-07
Abstract: A method of inserting a lipid-linked moiety into a lipid assembly, such as a planar lipid monolayer or bilayer, a spherical lipid vesicle, a micelle, or an emulsion envelope monolayer is described. In the method, the lipid assembly and the lipid-linked moiety are contacted in the presence of microwave irradiation to permit the lipid-linked moiety to become associated with the lipid assembly. In one embodiment, the lipid assembly is a liposome and the lipid-linked moiety is a lipid-polymer. Compositions comprised of a lipid layer and of a lipid-linked moiety, prepared in accord with the method, are also described.
Patent CA-2583004-A1 (CA)
Inventor: HARLAN JOHN M
IPC: A61K38/17
Filed: 2005-10-04
Abstract: In one aspect the present invention provides methods for inhibiting cell death or inflammation in a mammal, wherein the methods each include the step of administering to a mammal a Bcl protein in an amount sufficient to inhibit cell death or inflammation in the mammal. The invention also provides methods for identifying a Bcl protein that inhibits cell death or inflammation when administered to a mammal.
Patent CA-2584351-A1 (CA)
Title: Two-stage cylinder for automatic application and release of a hand brake of a railway vehicle
Inventor: SOMMERFELD HOWARD R
IPC: B61H13/04
Filed: 2005-10-14
Abstract: An apparatus engageable with a hand brake assembly which will automatically apply at least one brake secured to a railway vehicle with such hand brake assembly. The apparatus of the invention comprises an operating mechanism having at least a portion thereof engageable with at least one gear of a gear assembly disposed in a housing member of the hand brake assembly for operating such gear assembly. The operating mechanism is a two stage pneumatic cylinder (300) having a primary portion (308) for initial phase of the brake application and a secondary portion (310) for the final brake application to apply high forces to comply with AAR requirements. A source of fluid pressure is connected to the operating mechanism for periodically supplying a predetermined pressure to such operating means. A control device is connected to the source of the fluid pressure for initiating the supply of such predetermined pressure to the operating mechanism. A further control device is connected to the source of the fluid pressure for regulating the supply of such predetermined pressure to the operating mechanism thereby causing an automatic application of such brake by the hand brake assembly.
Patent CA-2587134-A1 (CA)
Title: Azine compounds for combating animal pests
Inventor: SHIEH HONG-MING
IPC: A01P5/00
Filed: 2005-11-25
Abstract: The present invention relates to new azine compounds which are useful combating animal pests, in particular insects and nematodes and to the salts thereof. The invention also relates to a method for combating insects, nematodes and arachnids. The azine compounds of the invention are described by the general formula (I) wherein ~ is absent or a covalent bond; n is 0 or 1, in paarticular 0; A is an optionally substituted cyclic radical selected from phenyl and a 5- or 6-membered heterocyclic radical with 1, 2, 3, or 4 heteroatoms; Ar is an optionally substituted aromatic radical selected from phenyl, pyridyl, pyrimidyl, furyl and thienyl, x is selected from halogen, OR7, SR7, SOR7,SO2R7, C1-C4-alkyl and C1-C4-haloalkyl; and wherein R1 to R4 and R7 are as described in the claims and the specification.
Patent CA-2588041-A1 (CA)
Title: Method of making nanocomposites
Inventor: NELSON JAMES M
IPC: C08K3/34
Filed: 2005-10-25
Abstract: A deprotectable polymer, activating agent, and layered silicate are combined and the deprotectable polymer is at least partially deprotected to form a composite. The composite may be combined with a polymeric resin to form a nanocomposite.
Patent CA-2588554-A1 (CA)
Inventor: DARUT ALAIN
IPC: B29C65/22
Filed: 2007-05-15
Abstract: L'invention concerne un dispositif et un procédé pour le soudage de deux pieces en polyméres par fusion. La fusion est obtenue moyennant une nappe chauffante (1) tricotée à partir d'un fil résistif revêtu d'un vernis isolant, la nappe chauffante (1) etant conformée pour être alimentée électriquement par un automate réglable en tension ou en intensité de courant et résistant aux courts-circuits. La nappe chauffante (1) est obtenue à partir d'un fil résistif ayant un diamètre allant de 0,2 mm à 0,3 mm, et présente des mailles (M) approximativement parallélépipédiques dont les dimensions (a, b) vont de 1,5 .times. 3 mm2 à 2,5 .times. 4,5 mm2.
Patent CA-2588564-A1 (CA)
Inventor: GE WANGMAO
IPC: C07K14/47
Filed: 2004-11-19
Abstract: A novel gene 158P3D2 and its encoded protein, and variants thereof, are described wherein 158P3D2 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table 1.  Consequently, 158P3D2 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 158P3D2 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 158P3D2 can be used in active or passive immunization.
Patent CA-2592260-A1 (CA)
Title: Vacuum sealer apparatus and a film cartridge for a vacuum sealer and a means of operating the vacuum sealer apparatus and the film cartridge
Inventor: TURVEY ROBERT R
IPC: B65B51/22
Filed: 2007-06-19
Abstract: A vacuum sealer for packaging, sealing and storing items and a film cartridge for a vacuum sealer is disclosed.  The vacuum sealer has a means to feed, form, seal and cut film bags for storing items. The vacuum sealer preferably includes a body, a top portion, a base portion, a film cartridge, a drive mechanism, a sealing and cutting mechanism and a vacuum/pump mechanism. The film cartridge is operatively positioned in a feed opening in a top portion of the vacuum sealer. The film cartridge houses film for forming film bags for use in the vacuum sealer. The film cartridge may have tubular film contained in a collapsed state or may have two film rolls which are brought together and sealed at the edges. The vacuum sealer may be used in a vertical orientation or optionally in a horizontal or angled orientation.
Patent CA-2593325-A1 (CA)
Title: Cancer prognostic, diagnostic and treatment methods
Inventor: JUBB ADRIAN M
IPC: C12Q1/68
Filed: 2006-01-05
Abstract: The invention disclosed herein provides methods comprising detection of EphB2 polypeptide and/or polynucleotide in a biological sample from a subject, wherein the detection of EphB2 is predictive or indicative of cancer prognosis for the subject. The invention also provides methods for selecting cancer treatment, methods comprising detection of EphB2 polypeptide and/or polynucleotide expression in colon adenomas, and methods for treating a colon adenoma disorder. Kits, compositions, and articles of manufacture are also provided.
Patent CA-2596091-A1 (CA)
Title: Vessel with mooring system, and mooring system
Inventor: HEIDEMAN RIK ROBERT
IPC: B63B22/04
Filed: 2007-08-03
Abstract: Vessel with mooring system, comprising a turret anchored to the seabed and a turret casing being part of the vessel, wherein the turret and turret casing are interconnected by a connecting element comprising a bearing arrangement and wherein the connecting element has a first end connected to the turret casing and an opposite second end connected to the turret. The connecting element is positioned in such a manner that it experiences tensile forces. When the turret downwardly loads the turret casing the first end of the connecting element is positioned at a higher level then the second end thereof. When the turret upwardly loads the turret casing the first end of the connecting element is positioned at a lower level then the second end thereof.
Patent CA-2599220-A1 (CA)
Inventor: GASCON IRENE
IPC: A61K31/7115
Filed: 2006-03-14
Abstract: Methods and compositions for the treatment of intestinal disorders, such as IBD and Crohn's disease, are disclosed. Preferred compositions include siNA.  Also disclosed is a method of specifically targeting siNA to treat intestinal disorders by intrarectal administration of siNA compounds.
Patent CA-2601115-A1 (CA)
Title: Antibodies against candida antigens
Inventor: LIU HAIQUN
IPC: C07K16/14
Filed: 2006-03-10
Abstract: Provision of domain antibodies. In particular, domain antibodies (dAbs) that recognize virulence traits of Candida spp. and confer passive protection against candidiasis.
Patent CA-2601272-A1 (CA)
Title: Liquid laundry detergent compositions with modified polyethyleneimine polymers and lipase enzyme
Inventor: SOUTER PHILIP FRANK
IPC: C11D3/386
Filed: 2006-04-12
Abstract: A liquid laundry detergent for improved grease and oil cleaning having a lipase enzyme, a modified polyethyleneimine polymer and a liquid carrier.
Patent CA-2604300-A1 (CA)
Inventor: SIENA SALVATORE
IPC: C07K16/28
Filed: 2006-04-12
Abstract: The invention relates to an individualized and personalized diagnosis and therapy of cancer based on specific molecular alterations which occur in specific tumor tissue of specific tumor patient populations. The therapy and diagnostic is based on the findings that proliferation and tumor growth of specific EGFR bearing tumor tissue expressing an amplified EGFR gene copy number may be abolished by anti-EGFR antibodies, while other individual molecular alterations such as mutations occurring in tumor tissues are unaffected by the same anti-EGFR antibody treatment.
Patent CA-2605468-A1 (CA)
Inventor: MCDONALD JEREMY N
IPC: C12P3/00
Filed: 2006-04-27
Abstract: Described herein are methods for producing chemical products by anaerobically fermenting a particular biomass using anaerobic bacteria. Such chemical products include hydrogen and other gases, acetic acid and other volatile organic acids, solvents, solids, and salts of volatile organic acids.
Patent CA-2606455-A1 (CA)
Title: Fastening device for externally fastening cables or lines to housings
Inventor: MARTIN VINCENT
IPC: F16D65/18
Filed: 2006-04-18
Abstract: The invention relates to a fastening device (54) for externally fastening cables or lines to housings (12), especially to the housing of brake cylinders, which device comprises a fastening pin (56) that can be locked in a breather (52) of the housing. The invention is characterized in that a connecting channel (64) is configured in the fastening pin (56) via which channel, in the locked state, the interior (50) of the housing (12) communicates with the atmosphere.
Patent CA-2611319-A1 (CA)
Title: Inhibitors of the .alpha.2.beta.1/gpia-iia integrin
Inventor: CHOI SUNGWOOK
IPC: A61K38/00
Filed: 2006-06-07
Abstract: Novel compounds inhibiting the integrin .alpha.2.beta.l/GPIa-IIa receptor are disclosed. Also disclosed are pharmaceutical compositions containing the compounds, as well as methods of their therapeutic use. The compounds disclosed are useful, inter alia, as inhibitors of integrin .alpha.2.beta.l/GPIa-IIa-mediated activity.
Patent CA-2612660-A1 (CA)
Title: Manufacturing methods for nanomaterial dispersion and products thereof
Inventor: YADAV TAPESH
IPC: B01F23/00
Filed: 2006-05-30
Abstract: Methods for manufacturing nanomaterial dispersions and related nanotechnology.  Nanomaterial concentrates that are cheaper to store and transport are described.
Patent CA-2615661-A1 (CA)
Inventor: HURST WILLIAM S
IPC: A61J1/05
Filed: 2002-02-15
Abstract: A hanger system for supporting a flexible medical container in a support container, comprises a support member adapted to be connected to a top portion of the support container and a hanger having a plurality of depending members adapted to be connected to the flexible container. The hanger is connected to the support member.
Patent CA-2617130-A1 (CA)
Title: Wheel suspension arm
Inventor: KOSCHINAT HUBERT B
IPC: B60G7/00
Filed: 2006-08-09
Abstract: The invention relates to a wheel suspension arm, especially a trailing arm (1) for a vehicle. Said wheel suspension arm comprises a link opening (12) for swivelably securing the wheel suspension arm to a vehicle frame and an axle opening (11) for securing an axle element (2) to the wheel suspension arm.  Said axle opening (11), on its peripheral edge (11a), comprises at least one discontinuation, such as e.g. a slot (13). The invention also relates to a method for producing the inventive wheel suspension arm and to a wheel suspension comprising said wheel suspension arm.
Patent CA-2617705-A1 (CA)
Inventor: GARCEAU BERNARD F
IPC: B60S9/04
Filed: 2008-01-10
Abstract: A stabilizing rod for a retractable stabilizing support for a vehicle, such as a recreational vehicle, a trailer, or the like, the stabilizing rod comprising: a longitudinally extendable and retractable member having a first end and a second end, the first end being configured to attach to one of a vehicle and a stabilizing support and the second end being configured to attach to the other of the vehicle and a stabilizing support, wherein one of the first and second ends includes a first rotation means that configured to rotate in more than one plane and the other of the first and second ends includes a second rotation means that rotates in at least one plane.
Patent CA-2618716-A1 (CA)
Inventor: BOWEN WILLIAM H
IPC: G01N33/573
Filed: 2006-08-14
Abstract: The present invention relates to antibodies, binding portions thereof, or probes that bind specifically to glucosyltransferase enzymes, and uses of these agents for detecting glucosyltransferase enzyme(s) in a sample and for diagnosing predisposition of a human child to early childhood caries. The present invention also relates to a kit for detecting a glucosyltransferase enzyme in an oral sample from an animal.
Patent CA-2620457-A1 (CA)
Inventor: BRADLEY ROGER M
IPC: H02H3/00
Filed: 2006-08-24
Abstract: Resettable circuit interrupting devices having self-test and non-resettable or limited resettable power interrupting systems are provided. The permanent power interrupting system activates when a circuit interrupting device is no longer capable of operating in accordance with applicable standards governing such devices or the device is no longer capable of operating in accordance with its design characteristics.
Patent CA-2621059-A1 (CA)
Inventor: AGELAND HANS
IPC: A61K31/5377
Filed: 2005-09-22
Abstract: A composition is provided, which comprises a serine protease; a reversible inhibitor of said serine protease; and a stabilizing agent M having the formula (I): Also provided are uses of the composition as a medicament, and other uses and methods employing its various properties .